Eli Lilly's obesity drug beats rival in head-to-head trial, where Cramer thinks stock will be next
The new trial data has cemented Club's lead position behind Eli Lilly in the highly competitive anti-obesity drug race. Eli…
LILLY DRN
Amgen says anti-obesity drug MariTide caused up to 20% weight loss after one year
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Eli Lilly's cholesterol pill impresses in trial
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
2 health stocks are buys. They're pretty disappointed with Trump RFK Jr.'s pick for HHS
We are purchasing 25 shares of Danaher at approximately $229 each. Following Monday's trade, Jim Cramer's Charitable Trust will own…
Jim Cramer's Top 10 Things to Watch for in the Stock Market on Friday
My Top 10 Things to Watch for Friday, Nov. 15 1. President-elect Donald Trump's decision to nominate prominent vaccine skeptic…
Jim Cramer on Eli Lilly (LLY) after Trump picks RFK Jr. to lead HHS
Enthusiasm for Eli Lilly, the club's holding company, needs to be tempered, at least for now, as Wall Street grapples…
Amgen Stock Falls on Weight Loss Drug's Bone Density Loss Data
Omar Marqués | Light rocket | fake images Actions of amgen fell more than 7% on Tuesday as analysts analyzed…
Race for weight-loss drugs intensifies with data on obesity pills
Aykut Karahan | Stock | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Why sales of Eli Lilly's Zepbound and Mounjaro fell short
Eli LillyBlockbuster weight-loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as supplies of…
Eli Lilly (LLY) earnings in the third quarter of 2024
The Lilly Biotechnology Center is shown in San Diego, California, USA, on March 1, 2023. Mike Blake | Reuters Eli…